Medisus Pharma

Mounjaro 15mg KwikPen is a once-weekly injection administered subcutaneously in the abdomen, thigh, or upper arm. It’s essential to rotate injection sites to prevent skin irritation and ensure the proper absorption of the medicine. Take the injection on the same day each week and at the same time, as missing doses or inconsistent use may reduce the effectiveness of the medicine.

Wegovy is a medication containing semaglutide, approved for chronic weight management, which begins with a lower initiation dosage designed to help the body adjust. It works by mimicking a GLP-1 hormone to reduce appetite and food intake, administered via subcutaneous injection in the abdomen, thigh, or arm. 

Wegovy 1mg FlexTouch supports long-term weight loss and weight maintenance in adults with obesity, adults with overweight who have at least one weight-related health condition, and adolescents aged 12 years and older with obesity. 

Wegovy Flextouch 2.4 mg PFP Combipack Injection 3 ml is used for chronic weight management in adults. It is prescribed alongside a reduced-calorie diet and increased physical activity to help achieve and maintain weight loss in patients with obesity or those who have weight-related health conditions.

Wegovy (semaglutide) is a once-weekly, subcutaneous injection designed to manage chronic weight issues by suppressing appetite and enhancing fullness. It is used as part of a structured, increasing dosage regimen, starting lower and progressing to higher levels to help manage weight through lifestyle changes. 

Mounjaro is a GLP-1 receptor agonist intended for use when lifestyle measures such as diet and exercise alone do not adequately control blood glucose levels. The Mounjaro 12.5 mg KwikPen is a prefilled, multi-dose pen designed for ease of self-administration at home. Each pen contains four fixed doses of the specified strength: for example, a 12.5 mg pen holds a total of 50 mg of tirzepatide (4 doses × 12.5 mg), 0.6 ml each. Patients inject one dose per week, so each pen is designed to last for one month.

Wegovy is a once-weekly injection used for chronic weight management, often initiated at a lower dose and increased gradually over several weeks to manage appetite and food intake. It is part of the semaglutide class, designed for individuals with obesity or overweight, typically used in conjunction with lifestyle modifications.